Analyst Research

Report Title Price
Provider: ValuEngine, Inc.
$49.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Hyperion Therapeutics Inc raises FY 2014 revenue guidance


Thursday, 7 Aug 2014 04:16pm EDT 

Hyperion Therapeutics Inc:Expects FY 2014 total net revenues to be in range of $105 mln to $110 mln.FY 2014 revenue of $89 mln - Thomson Reuters I/B/E/S. 

Company Quote

45.97
-0.02 -0.04%
11:53am EDT